{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:42:09Z","timestamp":1740109329192,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T00:00:00Z","timestamp":1516579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00059-017-4675-x","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T05:22:53Z","timestamp":1516598573000},"page":"433-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6\u2011month vs. 12\u2011month dual-antiplatelet therapy (DAPT)","Klinische Ergebnisse nach Behandlung mit polymerfreien sirolimusfreisetzenden Stents und 6\u2011 vs. 12\u2011monatiger dualer Thrombozytenaggregationshemmertherapie (DAPT) bei Diabetes"],"prefix":"10.1007","volume":"44","author":[{"given":"F.","family":"Krackhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Waliszewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rischner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Piot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pansieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. L.","family":"Ruiz-Poveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Boxberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Noutsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. F.","family":"R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1733-6646","authenticated-orcid":false,"given":"B.","family":"Kherad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"issue":"9670","key":"4675_CR1","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S0140-6736(09)60552-3","volume":"373","author":"MA Hlatky","year":"2009","unstructured":"Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM et\u00a0al (2009) Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a\u00a0collaborative analysis of individual patient data from ten randomised trials. Lancet 373(9670):1190\u20131197","journal-title":"Lancet"},{"issue":"8","key":"4675_CR2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/hrt.2005.075960","volume":"92","author":"SJ Hong","year":"2006","unstructured":"Hong SJ, Kim MH, Ahn TH, Ahn YK, Bae JH, Shim WJ et al (2006) Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart 92(8):1119\u20131124","journal-title":"Heart."},{"issue":"1","key":"4675_CR3","first-page":"31","volume":"32","author":"CC Wei","year":"2016","unstructured":"Wei CC, Shyu KG, Cheng JJ, Lo HM, Chiu CZ (2016) Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome \u2013 Data from Taiwan\u2019s Acute Coronary Syndrome Full Spectrum Data Registry. Acta Cardiol Sin 32(1):31\u201338","journal-title":"Acta Cardiol Sin"},{"issue":"4","key":"4675_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S0300-8932(09)70892-9","volume":"62","author":"R Iijima","year":"2009","unstructured":"Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ et al (2009) Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a\u00a0pooled analysis of individual patient data from seven randomized trials. Rev Esp Cardiol 62(4):354\u2013364","journal-title":"Rev Esp Cardiol"},{"issue":"4","key":"4675_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.2337\/dc12-1507","volume":"36","author":"G Luca De","year":"2013","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L et al (2013) Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation. Diabetes Care 36(4):1020\u20131025","journal-title":"Diabetes Care"},{"issue":"17","key":"4675_CR6","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293(17):2126\u20132130","journal-title":"JAMA"},{"issue":"2","key":"4675_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.amjcard.2014.04.035","volume":"114","author":"G El-Hayek","year":"2014","unstructured":"El-Hayek G, Messerli F, Bangalore S, Hong MK, Herzog E, Benjo A et al (2014) Meta-analysis of randomized clinical trials comparing short-term versus long-term dual antiplatelet therapy following drug-eluting stents. Am J Cardiol 114(2):236\u2013242","journal-title":"Am J Cardiol"},{"key":"4675_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ahj.2016.09.010","volume":"182","author":"A Grodzinsky","year":"2016","unstructured":"Grodzinsky A, Arnold SV, Wang TY, Sharma P, Gosch K, Jones PG et al (2016) Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy. Am Heart\u00a0J 182:111\u2013118","journal-title":"Am Heart J"},{"issue":"9665","key":"4675_CR9","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","volume":"373","author":"G Montalescot","year":"2009","unstructured":"Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH et al (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 373(9665):723\u2013731","journal-title":"Lancet"},{"issue":"2","key":"4675_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.7326\/M15-0083","volume":"163","author":"FA Spencer","year":"2015","unstructured":"Spencer FA, Prasad M, Vandvik PO, Chetan D, Zhou Q, Guyatt G (2015) Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis. Ann Intern Med 163(2):118\u2013126","journal-title":"Ann Intern Med"},{"issue":"9","key":"4675_CR11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","volume":"125","author":"L Raber","year":"2012","unstructured":"Raber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y et al (2012) Very late coronary stent thrombosis of a\u00a0newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a\u00a0prospective cohort study. Circulation 125(9):1110\u20131121","journal-title":"Circulation"},{"issue":"4","key":"4675_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ccd.26110","volume":"87","author":"KM Ziada","year":"2016","unstructured":"Ziada KM, Abdel-Latif A, Charnigo R, Moliterno DJ (2016) Safety of an abbreviated duration of dual antiplatelet therapy (\u3008\/=6\u00a0months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials. Catheter Cardiovasc Interv 87(4):722\u2013732","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"4675_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00059-016-4529-y","volume":"42","author":"F Krackhardt","year":"2017","unstructured":"Krackhardt F, Noutsias M, Tschope C, Kherad B (2017) DCB meets DES. Herz 42(7):696\u2013697","journal-title":"Herz"},{"issue":"17","key":"4675_CR14","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA et\u00a0al (2007) Clinical end points in coronary stent trials: a\u00a0case for standardized definitions. Circulation 115(17):2344\u20132351","journal-title":"Circulation"},{"issue":"3","key":"4675_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/ccd.26261","volume":"88","author":"M Leschke","year":"2016","unstructured":"Leschke M, Waliszewski M, Pons M, Champin S, Nait Saidi L, Mok Heang T et\u00a0al (2016) Thin strut bare metal stents in patients with atrial fibrillation: Is there still a\u00a0need for BMS? Catheter Cardiovasc Interv 88(3):358\u2013366","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"4675_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.111.026732","volume":"124","author":"S Massberg","year":"2011","unstructured":"Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J et al (2011) Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial. Circulation 124(5):624\u2013632","journal-title":"Circulation"},{"issue":"8","key":"4675_CR17","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jcin.2016.01.009","volume":"9","author":"S Kufner","year":"2016","unstructured":"Kufner S, Sorges J, Mehilli J, Cassese S, Repp J, Wiebe J, et al. Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents (2016) 5\u2011Year Results of the ISAR-TEST-5 Trial. Jacc Cardiovasc Interv 9(8):784\u2013792","journal-title":"Jacc Cardiovasc Interv"},{"issue":"3","key":"4675_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ccd.26597","volume":"89","author":"R Colleran","year":"2016","unstructured":"Colleran R, Kufner S, Harada Y, Giacoppo D, Cassese S, Repp J et al (2016) Five-year follow-up of polymer-free sirolimus- and probucol-eluting stents versus new generation zotarolimus-eluting stents in patients presenting with st-elevation myocardial infarction. Catheter Cardiovasc Interv 89(3):367\u2013374","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"4675_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-016-0429-y","volume":"15","author":"Y Harada","year":"2016","unstructured":"Harada Y, Colleran R, Kufner S, Giacoppo D, Rheude T, Michel J et al (2016) Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a\u00a0subgroup analysis of a\u00a0randomized controlled trial. Cardiovasc Diabetol 15(1):124","journal-title":"Cardiovasc Diabetol"},{"key":"4675_CR20","first-page":"3235","volume":"35(46","author":"P Kolh","year":"2014","unstructured":"Kolh P, Windecker S (2014) ESC\/EACTS myocardial revascularization guidelines 2014. Eur Heart\u00a0J 35(46:3235\u20133236","journal-title":"Eur Heart J"},{"issue":"18","key":"4675_CR21","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jacc.2012.07.040","volume":"60","author":"J Wohrle","year":"2012","unstructured":"Wohrle J, Zadura M, Mobius-Winkler S, Leschke M, Opitz C, Ahmed W et al (2012) SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a\u00a0large-scale, prospective registry study. J\u00a0Am Coll Cardiol 60(18):1733\u20131738","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4675_CR22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00059-015-4304-5","volume":"40","author":"C Liu","year":"2015","unstructured":"Liu C, Liu M, Chen D, Liu H, Jiang Q, Lu J et al (2015) Effectiveness of prolonged clopidogrel-based dual antiplatelet therapy after drug-eluting stent implantation: Evidence-based meta-analysis. Herz 40(5):795\u2013802","journal-title":"Herz"},{"issue":"8","key":"4675_CR23","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s00059-015-4325-0","volume":"40","author":"CF Chen","year":"2015","unstructured":"Chen CF, Chen B, Zhu J, Xu YZ (2015) Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis. Herz 40(8):1070\u20131083","journal-title":"Herz"},{"issue":"52","key":"4675_CR24","doi-asserted-by":"publisher","first-page":"e5819","DOI":"10.1097\/MD.0000000000005819","volume":"95","author":"PA Villablanca","year":"2016","unstructured":"Villablanca PA, Massera D, Mathew V, Bangalore S, Christia P, Perez I et al (2016) Outcomes of \u3008\/=6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression. Medicine (Baltimore) 95(52):e5819","journal-title":"Medicine (Baltimore)"},{"issue":"22","key":"4675_CR25","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1093\/eurheartj\/ehp275","volume":"30","author":"S Schulz","year":"2009","unstructured":"Schulz S, Schuster T, Mehilli J, Byrne RA, Ellert J, Massberg S et al (2009) Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a\u00a04-year period. Eur Heart\u00a0J 30(22):2714\u20132721","journal-title":"Eur Heart J"},{"issue":"3","key":"4675_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","volume":"125","author":"HC Gwon","year":"2012","unstructured":"Gwon HC, Hahn JY, Park KW, Song YB, Chae IH, Lim DS et al (2012) Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 125(3):505\u2013513","journal-title":"Circulation"},{"issue":"4","key":"4675_CR27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1479164111420890","volume":"8","author":"HM Hall","year":"2011","unstructured":"Hall HM, Banerjee S, McGuire DK (2011) Variability of clopidogrel response in patients with type 2 diabetes mellitus. Diab Vasc Dis Res 8(4):245\u2013253","journal-title":"Diab Vasc Dis Res"},{"issue":"24","key":"4675_CR28","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.jacc.2008.07.068","volume":"52","author":"D Erlinge","year":"2008","unstructured":"Erlinge D, Varenhorst C, Braun OO, James S, Winters KJ, Jakubowski JA et\u00a0al (2008) Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo. J\u00a0Am Coll Cardiol 52(24):1968\u20131977","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4675_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2337\/dc08-1865","volume":"32","author":"DJ Schneider","year":"2009","unstructured":"Schneider DJ (2009) Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care 32(4):525\u2013527","journal-title":"Diabetes Care"},{"issue":"13","key":"4675_CR30","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.jacc.2008.06.027","volume":"52","author":"DL Bhatt","year":"2008","unstructured":"Bhatt DL (2008) What makes platelets angry: diabetes, fibrinogen, obesity, and impaired response to antiplatelet therapy? J\u00a0Am Coll Cardiol 52(13):1060\u20131061","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"4675_CR31","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC et al (2015) Long-term use of ticagrelor in patients with prior myocardial infarction. N\u00a0Engl J Med 372(19):1791\u20131800","journal-title":"N Engl J Med"},{"issue":"23","key":"4675_CR32","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG et al (2014) Twelve or 30\u00a0months of dual antiplatelet therapy after drug-eluting stents. N\u00a0Engl J Med 371(23):2155\u20132166","journal-title":"N Engl J Med"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-017-4675-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-017-4675-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T12:15:55Z","timestamp":1566821755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-017-4675-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,22]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4675"],"URL":"https:\/\/doi.org\/10.1007\/s00059-017-4675-x","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2018,1,22]]},"assertion":[{"value":"14 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"F.\u00a0Krackhardt and M.\u00a0Noutsias have received lecturing fees from B.\u00a0Braun Melsungen AG . M.\u00a0Waliszewski and M.\u00a0Boxberger are currently full-time employed at Medical Scientific Affairs, B.\u00a0Braun Melsungen AG. J.\u00a0Rischner, C.\u00a0Piot, M.\u00a0Pansieri, F.L.\u00a0Ruiz-Poveda, X.F.\u00a0R\u00edos, and B.\u00a0Kherad declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975 (in its most recently amended version). Informed consent was obtained from all patients included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}